131 related articles for article (PubMed ID: 36099787)
21. Bleomycin in Hodgkin's Lymphoma - A Boon or a Bane? - A Retrospective Study of Bleomycin Pulmonary Toxicity in Hodgkin's Lymphoma.
Udupa CBK; Koteshwar P; Udupa KS
Indian J Palliat Care; 2019; 25(4):523-526. PubMed ID: 31673206
[TBL] [Abstract][Full Text] [Related]
22. The role of atopy in the pathogenesis of bleomycin pulmonary toxicity.
Ozyigit LP; Aktas EC; Senbas ZA; Ozturk AB; Ozturk E; Ergonul MO; Tabak L; Ferhanoglu B; Cetiner M; Deniz G
Respir Med; 2019 Aug; 155():1-5. PubMed ID: 31255902
[TBL] [Abstract][Full Text] [Related]
23. Possible toxicity with the association of G-CSF and bleomycin.
Bastion Y; Reyes F; Bosly A; Gisselbrecht C; Yver A; Gilles E; Maral J; Coiffier B
Lancet; 1994 May; 343(8907):1221-2. PubMed ID: 7513778
[No Abstract] [Full Text] [Related]
24. Bleomycin-Induced Pneumonitis in the Treatment of Ovarian Sex Cord-Stromal Tumors: A Systematic Review and Meta-analysis.
Delanoy N; Pécuchet N; Fabre E; Combe P; Juvin K; Pujade-Lauraine E; Oudard S
Int J Gynecol Cancer; 2015 Nov; 25(9):1593-8. PubMed ID: 26308607
[TBL] [Abstract][Full Text] [Related]
25. The Use of Filgrastim in Patients with Hodgkin Lymphoma Receiving ABVD.
Binder AF; Rai S; Steinberg A
Int J Hematol Oncol Stem Cell Res; 2017 Oct; 11(4):286-292. PubMed ID: 29340124
[No Abstract] [Full Text] [Related]
26. Intermittent granulocyte colony-stimulating factor maintains dose intensity after ABVD therapy complicated by neutropenia.
Ho P; Sherman P; Grigg A
Eur J Haematol; 2012 May; 88(5):416-21. PubMed ID: 22296221
[TBL] [Abstract][Full Text] [Related]
27. Serious pulmonary complications in patients receiving recombinant granulocyte colony-stimulating factor during BACOP chemotherapy for aggressive non-Hodgkin's lymphoma.
Lei KI; Leung WT; Johnson PJ
Br J Cancer; 1994 Nov; 70(5):1009-13. PubMed ID: 7524599
[TBL] [Abstract][Full Text] [Related]
28. G-CSF and GM-CSF for treating or preventing neonatal infections.
Carr R; Modi N; Doré C
Cochrane Database Syst Rev; 2003; 2003(3):CD003066. PubMed ID: 12917944
[TBL] [Abstract][Full Text] [Related]
29. Fatal bleomycin pulmonary toxicity in the west of Scotland 1991-95: a review of patients with germ cell tumours.
Simpson AB; Paul J; Graham J; Kaye SB
Br J Cancer; 1998 Oct; 78(8):1061-6. PubMed ID: 9792151
[TBL] [Abstract][Full Text] [Related]
30. Elevation of the erythrocyte sedimentation rate precedes exacerbation of bleomycin-induced pulmonary toxicity: report of two cases and review of literature.
Higa GM; AlKhouri N; Auber ML
Pharmacotherapy; 1997; 17(6):1315-21. PubMed ID: 9399618
[TBL] [Abstract][Full Text] [Related]
31. Death by bleomycin pulmonary toxicity in ovarian dysgerminoma with pathologic complete response to chemotherapy. A case report.
Calzas Rodríguez J; Carmen Juarez Morales MD; Casero MA
Respir Med Case Rep; 2016; 18():48-50. PubMed ID: 27330950
[TBL] [Abstract][Full Text] [Related]
32. Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy.
Skoetz N; Bohlius J; Engert A; Monsef I; Blank O; Vehreschild JJ
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007107. PubMed ID: 26687844
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary function abnormalities in childhood cancer survivors treated with bleomycin.
De A; Guryev I; LaRiviere A; Kato R; Wee CP; Mascarenhas L; Keens TG; Venkatramani R
Pediatr Blood Cancer; 2014 Sep; 61(9):1679-84. PubMed ID: 24789770
[TBL] [Abstract][Full Text] [Related]
34. Late pulmonary complications of treating Hodgkin lymphoma: bleomycin-induced toxicity.
Jóna Á; Miltényi Z; Ujj Z; Garai I; Szilasi M; Illés Á
Expert Opin Drug Saf; 2014 Oct; 13(10):1291-7. PubMed ID: 25135756
[TBL] [Abstract][Full Text] [Related]
35. Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke.
Bath PM; Sprigg N; England T
Cochrane Database Syst Rev; 2013 Jun; (6):CD005207. PubMed ID: 23797623
[TBL] [Abstract][Full Text] [Related]
36. Granulocyte colony-stimulating factor exacerbates the acute lung injury and pulmonary fibrosis induced by intratracheal administration of bleomycin in rats.
Adach K; Suzuki M; Sugimoto T; Suzuki S; Niki R; Oyama A; Uetsuka K; Nakamaya H; Doi K
Exp Toxicol Pathol; 2002 Feb; 53(6):501-10. PubMed ID: 11926293
[TBL] [Abstract][Full Text] [Related]
37. Bleomycin lung: the effect of different chemotherapeutic regimens.
Chisholm RA; Dixon AK; Williams MV; Oliver RT
Cancer Chemother Pharmacol; 1992; 30(2):158-60. PubMed ID: 1376217
[TBL] [Abstract][Full Text] [Related]
38. Prospective study of the pulmonary toxicity of continuously infused bleomycin.
Cooper KR; Hong WK
Cancer Treat Rep; 1981; 65(5-6):419-25. PubMed ID: 6165471
[TBL] [Abstract][Full Text] [Related]
39. Serum creatinine level during chemotherapy for testicular cancer as a possible predictor of bleomycin-induced pulmonary toxicity.
Kawai K; Hinotsu S; Tomobe M; Akaza H
Jpn J Clin Oncol; 1998 Sep; 28(9):546-50. PubMed ID: 9793027
[TBL] [Abstract][Full Text] [Related]
40. Colony-stimulating factors for chemotherapy-induced febrile neutropenia.
Mhaskar R; Clark OA; Lyman G; Engel Ayer Botrel T; Morganti Paladini L; Djulbegovic B
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD003039. PubMed ID: 25356786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
